Role of parenteral lipid emulsions in the preterm infant

Early Human Development

Volumn 89, Issue SUPPL2, 2013, Pages

  Nandivada, Prathima ^a   Carlson, Sarah J ^a   Cowan, Eileen ^a   Chang, Melissa I ^a   Gura, Kathleen M ^a   Puder, Mark ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOCOSAHEXAENOIC ACID; ESSENTIAL FATTY ACID; FISH OIL; LINOLENIC ACID; LIPID EMULSION; LIVER ENZYME; SOYBEAN OIL;

ARTICLE; BRAIN DEVELOPMENT; CHILD DEVELOPMENT; CHOLESTASIS; FATTY LIVER; HUMAN; INFANT FEEDING; INFANT NUTRITION; LIVER DISEASE; LIVER FAILURE; NEWBORN; PARENTERAL NUTRITION; PATHOGENESIS; PREMATURITY;

CATHETER-RELATED INFECTIONS; CHILD DEVELOPMENT; FAT EMULSIONS, INTRAVENOUS; FISH OILS; HUMANS; INFANT NUTRITIONAL PHYSIOLOGICAL PHENOMENA; INFANT, NEWBORN; INFANT, PREMATURE; LIVER DISEASES; NUTRITIONAL REQUIREMENTS; PARENTERAL NUTRITION; RISK FACTORS;

EID: 84885840601     PISSN: 03783782     EISSN: 18726232     Source Type: Journal    
DOI: 10.1016/j.earlhumdev.2013.08.005     Document Type: Article

References (70)

1. Alwayn I.P.J., Gura K., Nosé V., Zausche B., Javid P., Garza J., et al. Omega-3 fatty acid supplementation prevents hepatic steatosis in a murine model of nonalcoholic fatty liver disease. Pediatr Res 2005, 57(3):445-452. 10.1203/01.PDR.0000153672.43030.75.
2. Beale E.F., Nelson R.M., Bucciarelli R.L., Donnelly W.H., Eitzman D.V. The world wide web at: intrahepatic cholestasis associated with parenteral nutrition in premature infants 2013.
3. Beath S., Davies P., Papadopoulou A. Parenteral nutrition-related cholestasis in postsurgical neonates: multivariate analysis of risk factors. J Pediatr Surg 1996, 31(4):604-606.
4. Brenna J.T., Varamini B., Jensen R.G., Diersen-Schade D.A., Boettcher J.A., Arterburn L.M. Docosahexaenoic and arachidonic acid concentrations in human breast milk worldwide. Am J Clin Nutr 2007, 85(6):1457-1464. [Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/17556680].
5. Calder P.C. Immunomodulation by omega-3 fatty acids. Prostaglandins Leukot Essent Fatty Acids 2007, 77(5-6):327-335. 10.1016/j.plefa.2007.10.015.
6. Carlson S.E. Docosahexaenoic acid and arachidonic acid in infant development. Semin Neonatol 2001, 6(5):437-449. 10.1053/siny.2001.0093.
7. Carnielli V.P., Wattimena D.J., Luijendijk I.H., Boerlage A., Degenhart H.J., Sauer P.J. The very low birth weight premature infant is capable of synthesizing arachidonic and docosahexaenoic acids from linoleic and linolenic acids. Pediatr Res 1996, 40(1):169-174. 10.1203/00006450-199607000-00030.
8. Cavicchi M., Beau P., Crenn P., Degott C., Messing B. Prevalence of liver disease and contributing factors in patients receiving home parenteral nutrition for permanent intestinal failure. Ann Intern Med 2000, 132(7):525-532. [Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/10744588].
9. Chan S., McCowen K.C., Bistrian B.R., Thibault A., Keane-Ellison M., Forse R.A., et al. Incidence, prognosis, and etiology of end-stage liver disease in patients receiving home total parenteral nutrition. Surgery 1999, 126(1):28-34. 10.1067/msy.1999.98925.
10. Chen W.-Y., Lin S.-Y., Pan H.-C., Liao S.-L., Chuang Y.-H., Yen Y.-J., et al. Beneficial effect of docosahexaenoic acid on cholestatic liver injury in rats. J Nutr Biochem 2012, 23(3):252-264. 10.1016/j.jnutbio.2010.11.022.
11. Cheung H.M., Lam H.S., Tam Y.H., Lee K.H., Ng P.C. Rescue treatment of infants with intestinal failure and parenteral nutrition-associated cholestasis (PNAC) using a parenteral fish-oil-based lipid. Clin Nutr 2009, 28(2):209-212. 10.1016/j.clnu.2009.02.004.
12. Christensen R.D., Henry E., Wiedmeier S.E., Burnett J., Lambert D.K. Identifying patients, on the first day of life, at high-risk of developing parenteral nutrition-associated liver disease. J Perinatol 2007, 27(5):284-290. 10.1038/sj.jp.7211686.
13. Chung P.H.Y., Wong K.K.Y., Wong R.M.S., Tsoi N.S., Chan K.L., Tam P.K.H. Clinical experience in managing pediatric patients with ultra-short bowel syndrome using omega-3 fatty acid. Eur J Pediatr Surg 2010, 20(2):139-142. 10.1055/s-0029-1238283.
14. Clandinin M.T., Chappell J.E., Leong S., Heim T., Swyer P.R., Chance G.W. Extrauterine fatty acid accretion in infant brain: implications for fatty acid requirements. Early Hum Dev 1980, 4(2):131-138. [Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/7408743].
15. Clayton P.T., Whitfield P., Iyer K. The role of phytosterols in the pathogenesis of liver complications of pediatric parenteral nutrition. Nutrition 1998, 14(1):158-164. [Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/9437703].
16. Cober M.P., Killu G., Brattain A., Welch K.B., Kunisaki S.M., Teitelbaum D.H. Intravenous fat emulsions reduction for patients with parenteral nutrition-associated liver disease. J Pediatr 2012, 160(3):421-427. 10.1016/j.jpeds.2011.08.047.
17. Cole C.R., Hansen N.I., Higgins R.D., Ziegler T.R., Stoll B.J. Very low birth weight preterm infants with surgical short bowel syndrome: incidence, morbidity and mortality, and growth outcomes at 18 to 22months. Pediatrics 2008, 122(3):e573-e582. 10.1542/peds.2007-3449.
18. Colomb V., Jobert-Giraud A., Lacaille F., Goulet O., Fournet J.C., Ricour C. Role of lipid emulsions in cholestasis associated with long-term parenteral nutrition in children. JPEN J Parenter Enteral Nutr 2000, 24(6):345-350. [Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/11071594].
19. D'Ascenzo R., D'Egidio S., Angelini L., Bellagamba M.P., Manna M., Pompilio A., et al. Parenteral nutrition of preterm infants with a lipid emulsion containing 10% fish oil: effect on plasma lipids and long-chain polyunsaturated fatty acids. J Pediatr 2011, 159(1):33-38.e1. 10.1016/j.jpeds.2010.12.052.
20. De Dooy J.J., Mahieu L.M., Van Bever H.P. The role of inflammation in the development of chronic lung disease in neonates. Eur J Pediatr 2001, 160(8):457-463. 10.1007/s004310100785.
21. De Meijer V.E., Le H.D., Meisel J.A., Gura K.M., Puder M. Parenteral fish oil as monotherapy prevents essential fatty acid deficiency in parenteral nutrition-dependent patients. J Pediatr Gastroenterol Nutr 2010, 50(2):212-218. 10.1097/MPG.0b013e3181bbf51e.
22. Diamond I.R., Sterescu A., Pencharz P.B., Kim J.H., Wales P.W. Changing the paradigm: omegaven for the treatment of liver failure in pediatric short bowel syndrome. J Pediatr Gastroenterol Nutr 2009, 48(2):209-215. 10.1097/MPG.0b013e318182c8f6.
23. Dobbing J., Sands J. Quantitative growth and development of human brain. Arch Dis Child 1973, 48(10):757-767. [Retrieved from http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1648530&tool=pmcentrez&rendertype=abstract].
24. Drongowski R., Coran A. An analysis of factors contributing to the development of total parenteral nutrition-induced cholestasis. JPEN J Parenter Enteral Nutr 1989, 586-589.
25. Ehrenkranz R.A. Early, aggressive nutritional management for very low birth weight infants: what is the evidence?. Semin Perinatol 2007, 31(2):48-55. 10.1053/j.semperi.2007.02.001.
26. Ellegård L., Sunesson A., Bosaeus I. High serum phytosterol levels in short bowel patients on parenteral nutrition support. Clin Nutr 2005, 24(3):415-420. 10.1016/j.clnu.2005.01.001.
27. Farquharson J., Cockburn F., Patrick W.A., Jamieson E.C., Logan R.W. Infant cerebral cortex phospholipid fatty-acid composition and diet. Lancet 1992, 340(8823):810-813. [Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/1357244].
28. Fleming C.R., Smith L.M., Hodges R.E. Essential fatty acid deficiency in adults receiving total parenteral nutrition. Am J Clin Nutr 1976, 29(9):976-983. [Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/822704].
29. Freund H.R. Abnormalities of liver function and hepatic damage associated with total parenteral nutrition. Nutrition (Burbank, Los Angeles County, Calif.) 1991, 7(1):1-5. [discussion 5-6. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/1802177].
30. Gura K.M., Lee S., Valim C., Zhou J., Kim S., Modi B.P., et al. Safety and efficacy of a fish-oil-based fat emulsion in the treatment of parenteral nutrition-associated liver disease. Pediatrics 2008, 121(3):e678-e686. 10.1542/peds.2007-2248.
31. Gura K.M., Parsons S.K., Bechard L.J., Henderson T., Dorsey M., Phipatanakul W., et al. Use of a fish oil-based lipid emulsion to treat essential fatty acid deficiency in a soy allergic patient receiving parenteral nutrition. Clin Nutr 2005, 24(5):839-847. 10.1016/j.clnu.2005.05.020.
32. Haggarty P. Effect of placental function on fatty acid requirements during pregnancy. Eur J Clin Nutr 2004, 58(12):1559-1570. 10.1038/sj.ejcn.1602016.
33. Hay W.W. Strategies for feeding the preterm infant. Neonatology 2008, 94(4):245-254. 10.1159/000151643.
34. HOLMAN R.T. The ratio of trienoic: tetraenoic acids in tissue lipids as a measure of essential fatty acid requirement. J Nutr 1960, 70:405-410. [Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/14402760].
35. Innis S.M. Essential fatty acid transfer and fetal development. Placenta 2005, 26(Suppl. A):S70-S75. 10.1016/j.placenta.2005.01.005.
36. Innis Sheila M. Perinatal biochemistry and physiology of long-chain polyunsaturated fatty acids. J Pediatr 2003, 143(4 Suppl):S1-S8. [Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/14597908].
37. Iyer K.R., Spitz L., Clayton P. BAPS prize lecture: new insight into mechanisms of parenteral nutrition-associated cholestasis: role of plant sterols. British Association of Paediatric Surgeons. J Pediatr Surg 1998, 33(1):1-6. [Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/9473088].
38. Javid P.J., Greene A.K., Garza J., Gura K., Alwayn I.P.J., Voss S., et al. The route of lipid administration affects parenteral nutrition-induced hepatic steatosis in a mouse model. J Pediatr Surg 2005, 40(9):1446-1453. 10.1016/j.jpedsurg.2005.05.045.
39. Koletzko B., Goulet O., Hunt J., Krohn K., Shamir R. 1. Guidelines on Paediatric Parenteral Nutrition of the European Society of Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN) and the European Society for Clinical Nutrition and Metabolism (ESPEN), supported by the European Society of Paedia. J Pediatr Gastroenterol Nutr 2005, 41(Suppl. 2):S1-S87. [Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/16254497].
40. Kubota A., Okada A., Nezu R., Kamata S., Imura K., Takagi Y. Hyperbilirubinemia in neonates associated with total parenteral nutrition. JPEN J Parenter Enteral Nutr 1998, 12(6):602-606.
41. Kurvinen A., Nissinen M.J., Gylling H., Miettinen T.A., Lampela H., Koivusalo A.I., et al. Effects of long-term parenteral nutrition on serum lipids, plant sterols, cholesterol metabolism, and liver histology in pediatric intestinal failure. J Pediatr Gastroenterol Nutr 2011, 53(4):440-446. 10.1097/MPG.0b013e3182212130.
42. Larqué E., Demmelmair H., Berger B., Hasbargen U., Koletzko B. In vivo investigation of the placental transfer of (13)C-labeled fatty acids in humans. J Lipid Res 2003, 44(1):49-55. [Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/12518022].
43. Le H.D., Fallon E.M., Kalish B.T., De Meijer V.E., Meisel J.A., Gura K.M., et al. The effect of varying ratios of docosahexaenoic acid and arachidonic acid in the prevention and reversal of biochemical essential fatty acid deficiency in a murine model. Metabolism 2013, 62(4):499-508. 10.1016/j.metabol.2012.10.003.
44. Lilja H.E., Finkel Y., Paulsson M., Lucas S. Prevention and reversal of intestinal failure-associated liver disease in premature infants with short bowel syndrome using intravenous fish oil in combination with omega-6/9 lipid emulsions. J Pediatr Surg 2011, 46(7):1361-1367. 10.1016/j.jpedsurg.2010.12.021.
45. Ling P.-R., Puder M., Bistrian B.R. Purified fish oil eliminating linoleic and alpha linolenic acid meets essential fatty acid requirements in rats. Metabolism 2012, 61(10):1443-1451. 10.1016/j.metabol.2012.03.007.
46. Liu Y., Binz J., Numerick M.J., Dennis S., Luo G., Desai B., et al. Hepatoprotection by the farnesoid X receptor agonist GW4064 in rat models of intra- and extrahepatic cholestasis. J Clin Invest 2003, 112(11):1678-1687. 10.1172/JCI18945.
47. Llop J.M., Virgili N., Moreno-Villares J.M., García-Peris P., Serrano T., Forga M., Solanich J., et al. Phytosterolemia in parenteral nutrition patients: implications for liver disease development. Nutrition 2008, 24(11-12):1145-1152. 10.1016/j.nut.2008.06.017.
48. Meisel J.A., Le H.D., De Meijer V.E., Nose V., Gura K.M., Mulkern R.V., et al. Comparison of 5 intravenous lipid emulsions and their effects on hepatic steatosis in a murine model. J Pediatr Surg 2011, 46(4):666-673. 10.1016/j.jpedsurg.2010.08.018.
49. Morris S., Simmer K., Gibson R. Characterization of fatty acid clearance in premature neonates during intralipid infusion. Pediatr Res 1998, 43(2):245-249. 10.1203/00006450-199802000-00015.
50. Nehra D., Fallon E.M., Carlson S.J., Potemkin A.K., Hevelone N.D., Mitchell P.D., et al. Provision of a soy-based intravenous lipid emulsion at 1g/kg/d does not prevent cholestasis in neonates. JPEN J Parenter Enteral Nutr 2012, 10.1177/0148607112453072.
51. Nehra D., Le H.D., Fallon E.M., Carlson S.J., Woods D., White Y.A., et al. Prolonging the female reproductive lifespan and improving egg quality with dietary omega-3 fatty acids. Aging Cell 2012, 11(6):1046-1054. 10.1111/acel.12006.
52. Neu J. Gastrointestinal development and meeting the nutritional needs of premature infants. Am J Clin Nutr 2007, 85(2):629S-634S. [Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/17284768].
53. O'Donovan D.J., Fernandes C.J. Free radicals and diseases in premature infants. Antioxid Redox Signal 2004, 6(1):169-176. 10.1089/152308604771978471.
54. Pawlik D., Lauterbach R., Hurkała J. The efficacy of fish-oil based fat emulsion administered from the first day of life in very low birth weight newborns. Med Wieku Rozwoj 2011, 15(3):306-311. [Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/22006485].
55. Pawlik D., Lauterbach R., Turyk E. Fish-oil fat emulsion supplementation may reduce the risk of severe retinopathy in VLBW infants. Pediatrics 2011, 127(2):223-228. 10.1542/peds.2010-2427.
56. Pawlosky R.J., Hibbeln J.R., Novotny J.A., Salem N. Physiological compartmental analysis of alpha-linolenic acid metabolism in adult humans. J Lipid Res 2001, 42(8):1257-1265. [Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/11483627].
57. Peden V.H., Witzleben C.L., Skelton M.A. Total parenteral nutrition. J Pediatr 1971, 78(1):180-181.
58. Premkumar M.H., Carter B.A., Hawthorne K.M., King K., Abrams S.A. High rates of resolution of cholestasis in parenteral nutrition-associated liver disease with fish oil-based lipid emulsion monotherapy. J Pediatr 2012, 162(4):793-798.e1. 10.1016/j.jpeds.2012.10.019.
59. Puder M., Valim C., Meisel J.A., Le H.D., De Meijer V.E., Robinson E.M., et al. Parenteral fish oil improves outcomes in patients with parenteral nutrition-associated liver injury. Ann Surg 2009, 250(3):395-402. 10.1097/SLA.0b013e3181b36657.
60. Robinson D.T., Carlson S.E., Murthy K., Frost B., Li S., Caplan M. Docosahexaenoic and arachidonic acid levels in extremely low birth weight infants with prolonged exposure to intravenous lipids. J Pediatr 2013, 162(1):56-61. 10.1016/j.jpeds.2012.06.045.
61. Sanchez S.E., Braun L.P., Mercer L.D., Sherrill M., Stevens J., Javid P.J. The effect of lipid restriction on the prevention of parenteral nutrition-associated cholestasis in surgical infants. J Pediatr Surg 2013, 48(3):573-578. 10.1016/j.jpedsurg.2012.08.016.
62. Sant'Anna A.M.G.A., Altamimi E., Clause R.-F., Saab J., Mileski H., Cameron B., et al. Implementation of a multidisciplinary team approach and fish oil emulsion administration in the management of infants with short bowel syndrome and parenteral nutrition-associated liver disease. Can J Gastroenterol 2012, 26(5):277-280. [Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/22590701].
63. Singh M. Essential fatty acids, DHA and human brain. Indian J Pediatr 2005, 72(3):239-242. [Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/15812120].
64. Skouroliakou M., Konstantinou D., Agakidis C., Delikou N., Koutri K., Antoniadi M., et al. Cholestasis, bronchopulmonary dysplasia, and lipid profile in preterm infants receiving MCT/ω-3-PUFA-containing or soybean-based lipid emulsions. Nutr Clin Pract 2012, 27(6):817-824. 10.1177/0884533612454547.
65. Sondheimer J.M., Asturias E., Cadnapaphornchai M. Infection and cholestasis in neonates with intestinal resection and long-term parenteral nutrition. J Pediatr Gastroenterol Nutr 1998, 27(2):131-137.
66. Squires R.H., Duggan C., Teitelbaum D.H., Wales P.W., Balint J., Venick R., et al. Natural history of pediatric intestinal failure: initial report from the Pediatric Intestinal Failure Consortium. J Pediatr 2012, 161(4):723-8.e2. 10.1016/j.jpeds.2012.03.062.
67. Strijbosch R.A.M., Lee S., Arsenault D.A., Andersson C., Gura K.M., Bistrian B.R., et al. Fish oil prevents essential fatty acid deficiency and enhances growth: clinical and biochemical implications. Metabolism 2008, 57(5):698-707. 10.1016/j.metabol.2008.01.008.
68. Uauy R., Mena P., Wegher B., Nieto S., Salem N. Long chain polyunsaturated fatty acid formation in neonates: effect of gestational age and intrauterine growth. Pediatr Res 2000, 47(1):127-135. [Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/10625093].
69. Xu Z.-W., Li Y.-S. Pathogenesis and treatment of parenteral nutrition-associated liver disease. Hepatobiliary Pancreat Dis Int 2012, 11(6):586-593. [Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/23232629].
70. Yeh S.L., Chang K.Y., Huang P.C., Chen W.J. Effects of n-3 and n-6 fatty acids on plasma eicosanoids and liver antioxidant enzymes in rats receiving total parenteral nutrition. Nutrition 1997, 13(1):32-36. [Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/9058445].